Controversies in the Management of Endometrial Carcinoma

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td align="left"><i>Endometrioid adenocarcinoma</i></td></tr><tr><td align="left"> Variants: with squamous differentiation</td></tr><tr><td align="left"> Villoglandular</td></tr><tr><td align="left"> Secretory</td></tr><tr><td align="left"> with ciliated cells</td></tr><tr><td align="center" colspan="1"><hr/></td></tr><tr><td align="left"><i>Other adenocarcinomas</i></td></tr><tr><td align="left"> Mucinous carcinoma</td></tr><tr><td align="left"> Serous carcinoma</td></tr><tr><td align="left"> Clear-cell carcinoma</td></tr><tr><td align="left"> Mixed carcinoma</td></tr><tr><td align="left"> Squamous-cell carcinoma</td></tr><tr><td align="left"> Transitional-cell carcinoma</td></tr><tr><td align="left"> Small-cell carcinoma</td></tr><tr><td align="left"> Undifferentiated carcinoma</td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

WHO histological classification of endometrial carcinoma.

Obstetrics and Gynecology International

tab1

Table 1

Table 1: Controversies in the Management of Endometrial Carcinoma 